Rising cases of Breast Cancer drives the Growth of Handheld Fluorescence Imaging Devices Market Unveils Fact.MR
Handheld fluorescence imaging devices are used for diagnostics patients and offer advantages over conventional testing method by delivering results in short span of time. Therefore, with the help of such devices, it is possible for caregivers and doctors to provide immediate effective treatment and diagnosis to the patient.
The application of such devices are vast in modern healthcare such as venipuncture, wound healing and many other. For instance, on August 2018, FDA cleared MolecuLight® Inc.’s, which is a first of its kind handheld fluorescence imaging devices. In addition, this device documents and captures fluorescence information from surrounding tissues and wounds using still video and images in real-time.
Request for Brochure –https://www.factmr.com/connectus/sample?flag=B&rep_id=5266
Presently, a number of handheld fluorescence imaging devices manufacturers are engaged in efforts to improve the quality of such devices such as device is sterilizable along with less radiation emissions that leads to less radiation exposure to the surgical staff and patients.
Handheld Fluorescence Imaging Devices Market: Drivers and Restraint
Rising cases of breast cancer and chronic diseases around the globe is the primary factor driving the growth of handheld fluorescence imaging devices market. The rising cases of the breast cancer have shifted the focus of researchers on more improved technology providing new imaging tool that improves tumor visualization during the first surgery of breast cancer, hence driving the growth of handheld fluorescence imaging devices market.
Advancements in technology and technique is another determinant of the handheld fluorescence imaging devices market as represented by the development of complex procedures along with better efficiency of the devices such as PRODIGI, is a new handheld- fluorescence imaging devices which is used to differentiate between healthy breast tissues and tumor.
Besides, these devices helps to reduce emergency room overcrowding as the diagnosis speeds up. Handheld fluorescence imaging devices are transportable and portable.
On the other hand, diagnosis with handheld fluorescence imaging devices requires less time and may affect the understanding of the results along with storage of data. Thus, this is turn, is expected to hamper the growth of handheld fluorescence imaging devices market.
Enquire/Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5266
Handheld Fluorescence Imaging Devices Market: Segmentation
The global handheld fluorescence imaging devices market is classified on the basis of Product, Compatibility, and End User.
Based on Product, Handheld Fluorescence Imaging Devices market is segmented into the following:
- With Transducer
- Without Transducer
Based on Compatibility, Handheld Fluorescence Imaging Devices market is segmented into the following:
Based on End User, Handheld Fluorescence Imaging Devices market is segmented into the following:
Handheld Fluorescence Imaging: Impact of COVID 19
COVID-19 which, originated in the city of Wuhan, Mainland China, has spread aggressively to evolve into a global pandemic involving more than 170 countries. This pandemic has affected lives across the economic, social and political sphere. Treating COVID 19 infected patients is the primary focus of doctors and physicians alike at the moment, as this infection has no available cure.
A breakthrough at this moment can decrease the stock prices of handheld fluorescence imaging devices manufacturers due to decrease patient pool thereby hampering the growth of handheld fluorescence imaging devices procedures.
Handheld Fluorescence Imaging Market: Key Players
Examples of some of the market participants in handheld fluorescence imaging devices market are Smith & Nephew, Inc, Kent Imaging INC., General Electric Company, BLZ Technology Inc., Healcerion, Inc., Butterfly Network, Inc., Hunan Ramzed Medical Imaging Technology Co., Ltd., Koninklijke Philips N.V., Siemens and others
The research report on handheld fluorescence imaging devices market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on handheld fluorescence imaging devices market provides analysis and information according to market segments such as geographies, product, and industry.
The report covers exhaust analysis on Handheld Fluorescence Imaging Market:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Report on Handheld Fluorescence Imaging Market includes regional analysis:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, France, U.K, Spain, Russia)
- East Asia (China, Japan, South Korea)
- South Asia (India, ASEAN)
- Oceania (Australia, New Zealand)
- Middle East and Africa (GCC Countries, South Africa, Northern Africa)
Explore Fact.MR’s Coverage on the Healthcare Domain:
Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.
At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.
Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness upsurge growth during the year 2021-2031.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates